CURZION PHARMACEUTICALS
Curzion Pharmaceuticals is a privately held development-stage biopharma company, and its development-stage oral selective lysophosphatidic acid 1 receptor (LPAR1) antagonist, CZN001 (renamed HZN-825).
CURZION PHARMACEUTICALS
Industry:
Biotechnology Health Care Pharmaceutical
Founded:
2019-01-01
Address:
San Diego, California, United States
Country:
United States
Total Employee:
1+
Status:
Active
Total Funding:
0
Similar Organizations
Diartis Pharmaceuticals
Diartis Pharmaceuticals is a privately held biopharmaceutical company.
G3 Pharmaceuticals
G3 pharmaceuticals is a development-stage biopharmaceutical company.
Harkness Pharmaceuticals
Harkness Pharmaceuticals is a privately-held development stage biopharmaceutical company.
Investors List
New Enterprise Associates
New Enterprise Associates investment in Venture Round - Curzion Pharmaceuticals